Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5691 studies found for:    "Diabetes Mellitus, Type 2"
Show Display Options
Rank Status Study
21 Completed Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin
22 Completed Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin
23 Completed Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: vildagliptin;   Drug: Gliclazide;   Drug: Metformin
24 Completed Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin
25 Completed Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: vildagliptin;   Drug: glimepiride;   Drug: Metformin;   Drug: Vildagliptin matching placebo;   Drug: Glimepiride matching placebo
26 Completed Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin
27 Completed Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin
28 Completed Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: vildagliptin;   Drug: Glimepiride;   Drug: LAF237 placebo
29 Completed Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: vildagliptin;   Drug: Metformin Comparator
30 Completed Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Vildagliptin;   Drug: pioglitazone;   Drug: Placebo
31 Completed Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: vildagliptin;   Drug: Gliclazide
32 Completed Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin
33 Terminated
Has Results
An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: rosiglitazone/glimepiride fix dose combination;   Drug: glimepiride
34 Completed Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin
35 Completed Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Rosiglitazone/metformin
36 Completed A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin
37 Completed Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin
38 Completed A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: vildagliptin;   Drug: placebo
39 Completed A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin
40 Completed Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: vildagliptin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.